AirSculpt Technologies, Inc. received an updated Schedule 13G/A from a group of Vesey Street Capital–affiliated investors led by Adam T. Feinstein reporting significant beneficial ownership of its common stock. The filing is based on 72,095,209 shares of common stock outstanding as of August 7, 2026.
EBS Aggregator Blocker Holdings, LLC reports beneficial ownership of 11,761,462 shares, or 16.3% of the class, including shares over which it may be deemed to share voting power through a Proxy and Voting Agreement with Thrivent White Rose Fund XI Equity Direct, L.P. VSCP EBS Aggregator, L.P. reports 14,038,819 shares (19.5%), and Vesey Street Capital Partners Healthcare Fund-A, L.P. reports 4,523,899 shares (6.3%), each with shared voting and dispositive power over their directly held shares.
Adam T. Feinstein and Vesey Street Capital Partners, L.L.C. each report beneficial ownership and shared voting power over 30,324,180 shares, or 42.1% of the class, reflecting their control relationships with the Vesey-affiliated entities and shared voting rights over 5,169,820 Thrivent shares. Each reporting person disclaims beneficial ownership beyond their pecuniary interest.
Shares outstanding72,095,209 sharesCommon stock outstanding as of August 7, 2026
Feinstein/Vesey beneficial ownership30,324,180 shares (42.1%)Shares over which Adam T. Feinstein and Vesey Street Capital Partners, L.L.C. report beneficial ownership
VSCP EBS Aggregator holdings14,038,819 shares (19.5%)Common stock held directly by VSCP EBS Aggregator, L.P.
Healthcare Fund-A holdings4,523,899 shares (6.3%)Common stock held directly by Vesey Street Capital Partners Healthcare Fund-A, L.P.
EBS Aggregator Blocker holdings6,591,642 sharesCommon stock held directly by EBS Aggregator Blocker Holdings, LLC
Thrivent shares under voting agreement5,169,820 sharesCommon stock held directly by Thrivent White Rose Fund XI Equity Direct, L.P.
EBS Aggregator Blocker beneficial stake11,761,462 shares (16.3%)Beneficial ownership including shared voting power with Thrivent
Key Terms
beneficial ownership, shared voting power, dispositive power, Proxy and Voting Agreement, +1 more
5 terms
beneficial ownershipfinancial
"Each of the Reporting Persons disclaims beneficial ownership of any securities that exceed"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting powerfinancial
"Vesey and EBS Aggregator Blocker may be deemed to share voting power over such shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
dispositive powerfinancial
"Vesey and EBS Aggregator Blocker do not have dispositive power over the shares held"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
Proxy and Voting Agreementfinancial
"pursuant to that certain Proxy and Voting Agreement between Vesey and Thrivent dated"
pecuniary interestfinancial
"disclaims beneficial ownership of any securities that exceed their pecuniary interest therein"
What stake in AirSculpt Technologies (AIRS) does Adam T. Feinstein report in this Schedule 13G/A?
Adam T. Feinstein reports beneficial ownership of 30,324,180 shares of AirSculpt Technologies common stock, representing 42.1% of the class, through Vesey Street Capital–affiliated entities and shared voting power over Thrivent-held shares.
How many AirSculpt Technologies (AIRS) shares does VSCP EBS Aggregator, L.P. own?
VSCP EBS Aggregator, L.P. reports beneficial ownership of 14,038,819 shares of AirSculpt Technologies common stock, equal to 19.5% of the outstanding class, with shared voting and dispositive power over all of those shares.
What is EBS Aggregator Blocker Holdings, LLC’s ownership percentage in AirSculpt Technologies (AIRS)?
EBS Aggregator Blocker Holdings, LLC reports beneficial ownership of 11,761,462 shares of AirSculpt Technologies, representing 16.3% of the common stock, including shares subject to shared voting power under a Proxy and Voting Agreement with Thrivent.
How many AirSculpt Technologies (AIRS) shares are outstanding for the ownership calculations?
The reported ownership percentages are calculated using 72,095,209 shares of AirSculpt Technologies common stock outstanding as of August 7, 2026, as referenced from the company’s unaudited condensed consolidated financial statements.
What is the role of the Proxy and Voting Agreement with Thrivent in AirSculpt Technologies (AIRS) ownership?
Under a Proxy and Voting Agreement dated May 20, 2026, Vesey Street Capital Partners, L.L.C. and EBS Aggregator Blocker may be deemed to share voting power over 5,169,820 shares of AirSculpt held directly by Thrivent, while Thrivent retains dispositive power.
Do the reporting persons in the AirSculpt Technologies (AIRS) Schedule 13G/A claim full beneficial ownership of all reported shares?
Each reporting person expressly disclaims beneficial ownership of any AirSculpt Technologies securities exceeding their pecuniary interest, even though they may be deemed to share voting or dispositive power through control relationships or agreements.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)
Airsculpt Technologies, Inc.
(Name of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
009496100
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
009496100
1
Names of Reporting Persons
EBS Aggregator Blocker Holdings, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,761,462.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,591,642.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,761,462.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
16.3 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: Rows (6) and (9): Consist of 6,591,642 shares of Common Stock held directly by EBS Aggregator Blocker Holdings, LLC, a Delaware limited liability company ("EBS Aggregator Blocker"), plus 5,169,820 shares of Common Stock held directly by Thrivent White Rose Fund XI Equity Direct, L.P. ("Thrivent"), over which Vesey Street Capital Partners, L.L.C. ("Vesey"), a Delaware limited liability company and the manager of EBS Aggregator Blocker, may be deemed to share voting power with EBS Aggregator Blocker pursuant to that certain Proxy and Voting Agreement between Vesey and Thrivent dated May 20, 2026 (the "Proxy and Voting Agreement"). Vesey and EBS Aggregator Blocker do not have dispositive power over the shares held by Thrivent. The Reporting Persons have not been furnished information regarding any disposition of such shares by Thrivent and, for purposes of this Schedule 13G, have assumed that Thrivent continued to hold all such shares as of the date of this Schedule 13G.
Row (8): Consists of 6,591,642 shares of Common Stock held directly by EBS Aggregator Blocker.
Row (11): This percentage is calculated based on 72,095,209 shares of Common Stock outstanding as of August 7, 2026, as set forth in the Issuer's Unaudited Condensed Consolidated Financial Statements for the period ended June 30, 2026, filed with the Securities and Exchange Commission on August 10, 2026.
SCHEDULE 13G
CUSIP Number(s):
009496100
1
Names of Reporting Persons
Adam T Feinstein
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
30,324,180.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
25,154,360.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
30,324,180.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
42.1 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: Rows (6) and (9): Consist of the 25,154,360 shares of Common Stock held directly by VSCP EBS Aggregator, L.P., a Delaware limited partnership ("VSCP EBS Aggregator"), Vesey Street Capital Partners Healthcare Fund-A, L.P., a Delaware limited partnership ("VSCP Healthcare Fund-A"), and EBS Aggregator Blocker in the aggregate, plus 5,169,820 shares of Common Stock held directly by Thrivent, over which Vesey and EBS Aggregator Blocker may be deemed to share voting power pursuant to the Proxy and Voting Agreement. Vesey and EBS Aggregator Blocker do not have dispositive power over the shares held by Thrivent. The Reporting Persons have not been furnished information regarding any disposition of such shares by Thrivent and, for purposes of this Schedule 13G, have assumed that Thrivent continued to hold all such shares as of the date of this Schedule 13G.
Row (8): Consists of 14,038,819 shares of Common Stock held directly by VSCP EBS Aggregator, 4,523,899 shares of Common Stock held directly by VSCP Healthcare Fund-A, and 6,591,642 shares of Common Stock held directly by EBS Aggregator Blocker. Mr. Feinstein serves as managing partner of Vesey, which is the manager of EBS Aggregator Blocker and the general partner of Vesey Street Capital Partners Healthcare GP, L.P., a Delaware limited partnership, which serves as the general partner of VSCP EBS Aggregator and VSCP Healthcare Fund-A.
Row (11): This percentage is calculated based on 72,095,209 shares of Common Stock outstanding as of August 7, 2026, as set forth in the Issuer's Unaudited Condensed Consolidated Financial Statements for the period ended June 30, 2026, filed with the Securities and Exchange Commission on August 10, 2026.
SCHEDULE 13G
CUSIP Number(s):
009496100
1
Names of Reporting Persons
VSCP EBS Aggregator, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
14,038,819.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
14,038,819.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
14,038,819.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
19.5 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: Rows (6), (8), and (9): Consist of 14,038,819 shares of Common Stock held directly by VSCP EBS Aggregator.
Row (11): This percentage is calculated based on 72,095,209 shares of Common Stock outstanding as of August 7, 2026, as set forth in the Issuer's Unaudited Condensed Consolidated Financial Statements for the period ended June 30, 2026, filed with the Securities and Exchange Commission on August 10, 2026.
SCHEDULE 13G
CUSIP Number(s):
009496100
1
Names of Reporting Persons
Vesey Street Capital Partners Healthcare Fund-A, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,523,899.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,523,899.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,523,899.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.3 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: Rows (6), (8), and (9): Consist of 4,523,899 shares of Common Stock held directly by VSCP Healthcare Fund-A.
Row (11): This percentage is calculated based on 72,095,209 shares of Common Stock outstanding as of August 7, 2026, as set forth in the Issuer's Unaudited Condensed Consolidated Financial Statements for the period ended June 30, 2026, filed with the Securities and Exchange Commission on August 10, 2026.
SCHEDULE 13G
CUSIP Number(s):
009496100
1
Names of Reporting Persons
Vesey Street Capital Partners, L.L.C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
30,324,180.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
25,154,360.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
30,324,180.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
42.1 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: Rows (6) and (9): Consist of the 25,154,360 shares of Common Stock held directly by VSCP EBS Aggregator, VSCP Healthcare Fund-A, and EBS Aggregator Blocker in the aggregate, plus 5,169,820 shares of Common Stock held directly by Thrivent, over which Vesey and EBS Aggregator Blocker may be deemed to share voting power pursuant to the Proxy and Voting Agreement. Vesey does not have dispositive power over the shares held by Thrivent. The Reporting Persons have not been furnished information regarding any disposition of such shares by Thrivent and, for purposes of this Schedule 13G, have assumed that Thrivent continued to hold all such shares as of the date of this Schedule 13G.
Row (8): Consists of 14,038,819 shares of Common Stock held directly by VSCP EBS Aggregator, 4,523,899 shares of Common Stock held directly by VSCP Healthcare Fund-A, and 6,591,642 shares of Common Stock held directly by EBS Aggregator Blocker. Mr. Feinstein serves as managing partner of Vesey Street Capital Partners, L.L.C., a Delaware limited liability company, which is the manager of EBS Aggregator Blocker Holdings, LLC and the general partner of Vesey Street Capital Partners Healthcare GP, L.P., a Delaware limited partnership, which serves as the general partner of VSCP EBS Aggregator, L.P. and Vesey Street Capital Partners Healthcare Fund-A, L.P.
Row (11): This percentage is calculated based on 72,095,209 shares of Common Stock outstanding as of August 7, 2026, as set forth in the Issuer's Unaudited Condensed Consolidated Financial Statements for the period ended June 30, 2026, filed with the Securities and Exchange Commission on August 10, 2026.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Airsculpt Technologies, Inc.
(b)
Address of issuer's principal executive offices:
c/o AirSculpt Technologies, Inc., 1111 Lincoln Road, Suite 802, Miami Beach, Florida 33139
Item 2.
(a)
Name of person filing:
The persons filing this statement are Adam T Feinstein, VSCP EBS Aggregator, L.P., Vesey Street Capital Partners Healthcare Fund-A, L.P., EBS Aggregator Blocker Holdings, LLC, and Vesey Street Capital Partners, L.L.C. Together, Adam T Feinstein, VSCP EBS Aggregator, L.P., Vesey Street Capital Partners Healthcare Fund-A, L.P., EBS Aggregator Blocker Holdings, LLC, and Vesey Street Capital Partners, L.L.C. are the "Reporting Persons."
(b)
Address or principal business office or, if none, residence:
c/o AirSculpt Technologies, Inc.
1111 Lincoln Road, Suite 802
Miami Beach, Florida 33139
(c)
Citizenship:
Adam Feinstein is a United States citizen.
VSCP EBS Aggregator, L.P. is a Delaware limited partnership.
Vesey Street Capital Partners Healthcare Fund-A, L.P. is a Delaware limited partnership.
EBS Aggregator Blocker Holdings, LLC is a Delaware limited liability company.
Vesey Street Capital Partners, L.L.C. is a Delaware limited liability company.
(d)
Title of class of securities:
Common Stock, $0.001 par value per share
(e)
CUSIP No.:
009496100
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
See Exhibit 99.2 hereto.
(b)
Percent of class:
See Exhibit 99.2 hereto.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See Exhibit 99.2 hereto.
(ii) Shared power to vote or to direct the vote:
See Exhibit 99.2 hereto.
(iii) Sole power to dispose or to direct the disposition of:
See Exhibit 99.2 hereto.
(iv) Shared power to dispose or to direct the disposition of:
See Exhibit 99.2 hereto.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Mr. Feinstein may be deemed to beneficially own, and have voting and dispositive power over, the shares of Common Stock held directly by VSCP EBS Aggregator, L.P. ("VSCP EBS Aggregator"), EBS Aggregator Blocker Holdings, LLC ("EBS Aggregator Blocker"), and Vesey Street Capital Partners Healthcare Fund-A, L.P. ("VSCP Healthcare Fund-A") through his role as managing partner of Vesey Street Capital Partners, L.L.C. ("Vesey"), which serves as the manager of EBS Aggregator Blocker and general partner of Vesey Street Capital Partners Healthcare GP, L.P., which serves as general partner of VSCP EBS Aggregator and VSCP Healthcare Fund-A. Each of the Reporting Persons disclaims beneficial ownership of any securities that exceed their pecuniary interest therein.
Thrivent White Rose Fund XI Equity Direct, L.P. ("Thrivent") may be deemed to beneficially own, and have dispositive power over, the 5,169,820 shares of Common Stock held directly by it. Vesey and EBS Aggregator Blocker may be deemed to share voting power over such shares pursuant to that certain Proxy and Voting Agreement between Vesey and Thrivent dated May 20, 2026 (the "Proxy and Voting Agreement"). Vesey and EBS Aggregator Blocker do not have dispositive power over the shares held by Thrivent. The Reporting Persons have not been furnished information regarding any disposition of such shares by Thrivent and, for purposes of this Schedule 13G, have assumed that Thrivent continued to hold all such shares as of the date of this Schedule 13G.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
EBS Aggregator Blocker Holdings, LLC
Signature:
/s/ Adam T. Feinstein
Name/Title:
Authorized Signatory
Date:
08/12/2026
Adam T Feinstein
Signature:
/s/ Adam T. Feinstein
Name/Title:
Adam T. Feinstein
Date:
08/12/2026
VSCP EBS Aggregator, L.P.
Signature:
/s/ Adam T. Feinstein
Name/Title:
Authorized Signatory
Date:
08/12/2026
Vesey Street Capital Partners Healthcare Fund-A, L.P.
Signature:
/s/ Adam T. Feinstein
Name/Title:
Adam T. Feinstein
Date:
08/12/2026
Vesey Street Capital Partners, L.L.C.
Signature:
/s/ Adam T. Feinstein
Name/Title:
Authorized Signatory
Date:
08/12/2026
Exhibit Information
Exhibit 99.1 - Joint Filing Agreement (incorporated herein by reference to Exhibit 99.1 to the Schedule 13G filed with the SEC by the Reporting Persons on February 11, 2022)
Exhibit 99.2 - Additional Information
